Home
NICE Guidance
NICE Advice
Evidence summaries

Chronic obstructive pulmonary disease: tiotropium/olodaterol (Spiolto Respimat)

Evidence summary [ESNM72] Published: 10 May 2016

Advice

This evidence summary has been updated and replaced by NICE guideline 115.